Development of constrained peptide inhibitors targeting an oncogenic E3 ubiquitin ligase (2023)
Attributed to:
Development of an Integrated Microfluidic Platform for the Identification of Therapeutic Peptides for Unmet Medical Needs
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2023.04.27.535981
Publication URI: http://dx.doi.org/10.1101/2023.04.27.535981
Type: Preprint